COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...

On the eve of RFK Jr.'s confirmation hearings, their cousin, Caroline Kennedy, urged lawmakers to reject his nomination saying he's led other family members “down the path of drug addiction.” ...

“We have made important progress by initiating our rolling new drug application (“NDA”) submission and announcing new data from our open label extension study, STARS Extend, demonstrating an ...

Regulatory Path and Exclusivity ... Awakn also completed a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA), which confirmed that AWKN-002 can be ...

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September 14, 2025. This NDA acceptance represents a pivotal ... Inc. Bumetanide Nasal Spray is an investigational ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...